CIK 0001125345 · Non-accelerated filer<br>Smaller reporting company
MACROGENICS INC
Sign in to watch- Ticker
- MGNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 301-251-5172
- Business address
- 9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $129,086
- in 1 filing, $129K under 10b5-1 plans
Net −$129,086. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-04 | Risser Eric Blasius Chief Operating Officer | Option exercise · Employee stock option (right to buy) 10b5-1 | −15,000 | 155,000 | ||
| 2024-03-04 | Spitznagel Thomas Sr VP, Technical Ops | Option exercise 10b5-1 | +10,000 | $11.50 | $115K | 18,316 |
| 2024-03-04 | Spitznagel Thomas Sr VP, Technical Ops | Sale 10b5-1 | −10,000 | $20.00 | $200K | 8,316 |
| 2024-03-04 | Spitznagel Thomas Sr VP, Technical Ops | Option exercise · Employee stock option (right to buy) 10b5-1 | −10,000 | 77,000 | ||
| 2024-03-04 | Karrels James SVP, CFO and Secretary | Sale 10b5-1 | −30,000 | $20.50 | $615K | 171,452 |
| 2024-02-26 | Peters Jeffrey Stuart Senior VP and General Counsel | Sale 10b5-1 | −16,124 | $17.22 | $278K | 8,895 |
| 2024-02-22 | Peters Jeffrey Stuart Senior VP and General Counsel | Option exercise | +26,250 | 35,145 | ||
| 2024-02-22 | Peters Jeffrey Stuart Senior VP and General Counsel | Shares withheld for taxes | −10,126 | $17.11 | $173K | 25,019 |
| 2024-02-22 | Peters Jeffrey Stuart Senior VP and General Counsel | Option exercise · Restricted Stock Unit | −26,250 | 0 | ||
| 2024-02-22 | Bonvini Ezio Sr VP, Research & CSO | Option exercise | +28,125 | 110,258 | ||
| 2024-02-22 | Bonvini Ezio Sr VP, Research & CSO | Shares withheld for taxes | −9,366 | $17.11 | $160K | 100,892 |
| 2024-02-22 | Bonvini Ezio Sr VP, Research & CSO | Option exercise · Restricted Stock Unit | −28,125 | 0 | ||
| 2024-02-15 | Eck Stephen L. Chief Medical Officer | Option exercise | +16,670 | 16,670 | ||
| 2024-02-15 | Eck Stephen L. Chief Medical Officer | Shares withheld for taxes | −6,872 | $17.40 | $120K | 9,798 |
| 2024-02-15 | Eck Stephen L. Chief Medical Officer | Option exercise · Restricted Stock Unit | −16,670 | 33,330 | ||
| 2024-02-15 | Peters Jeffrey Stuart Senior VP and General Counsel | Option exercise | +13,336 | 13,336 | ||
| 2024-02-15 | Peters Jeffrey Stuart Senior VP and General Counsel | Shares withheld for taxes | −4,441 | $17.40 | $77K | 8,895 |
| 2024-02-15 | Peters Jeffrey Stuart Senior VP and General Counsel | Option exercise · Restricted Stock Unit | −13,336 | 26,664 | ||
| 2024-02-15 | Koenig Scott President and CEO | Option exercise | +42,341 | 1,091,977 | ||
| 2024-02-15 | Koenig Scott President and CEO | Shares withheld for taxes | −14,349 | $17.40 | $250K | 1,077,628 |
Page 15 of 17 · 322 trades